Leo brings more than 25 years of deep cross-functional commercial and clinical development experience across both biologics and small molecules. Leo has built brands across multiple therapeutic areas, with focus in specialty, rare disease, and Orphan Drug markets throughout all phases of drug development.
Leo has held various leadership roles across marketing, business development, and alliance leadership at leading firms such as AstraZeneca, Merck, Astra Merck, and Regeneron. He received an MBA from Harvard Business School, a BS in Business Administration from West Virginia University and executive leadership certifications from Northwestern University and University of Pennsylvania.